BEAM
Price
$27.50
Change
+$0.22 (+0.81%)
Updated
Jan 31, 01:12 PM (EDT)
Capitalization
2.26B
32 days until earnings call
ETNB
Price
$9.65
Change
+$0.01 (+0.10%)
Updated
Jan 31, 10:49 AM (EDT)
Capitalization
1.03B
47 days until earnings call
Ad is loading...

BEAM vs ETNB

Header iconBEAM vs ETNB Comparison
Open Charts BEAM vs ETNBBanner chart's image
Beam Therapeutics
Price$27.50
Change+$0.22 (+0.81%)
Volume$400
Capitalization2.26B
89bio
Price$9.65
Change+$0.01 (+0.10%)
Volume$800
Capitalization1.03B
BEAM vs ETNB Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. ETNB commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and ETNB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (BEAM: $27.28 vs. ETNB: $9.64)
Brand notoriety: BEAM and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 92% vs. ETNB: 296%
Market capitalization -- BEAM: $2.26B vs. ETNB: $1.03B
BEAM [@Biotechnology] is valued at $2.26B. ETNB’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and ETNB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while ETNB’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • ETNB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ETNB is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +3.77% price change this week, while ETNB (@Biotechnology) price change was +39.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.84%. For the same industry, the average monthly price growth was +1.79%, and the average quarterly price growth was +5.50%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

ETNB is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.26B) has a higher market cap than ETNB($1.03B). ETNB YTD gains are higher at: 23.274 vs. BEAM (10.000). BEAM has higher annual earnings (EBITDA): -160.83M vs. ETNB (-279.65M). BEAM has more cash in the bank: 926M vs. ETNB (424M). ETNB has less debt than BEAM: ETNB (37.6M) vs BEAM (162M). BEAM has higher revenues than ETNB: BEAM (350M) vs ETNB (0).
BEAMETNBBEAM / ETNB
Capitalization2.26B1.03B220%
EBITDA-160.83M-279.65M58%
Gain YTD10.00023.27443%
P/E RatioN/AN/A-
Revenue350M0-
Total Cash926M424M218%
Total Debt162M37.6M431%
TECHNICAL ANALYSIS
Technical Analysis
BEAMETNB
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 25 days ago
81%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 24 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAGX20.110.28
+1.41%
Nationwide Janus Henderson Overseas A
OCSGX7.330.09
+1.24%
Optimum Small-Mid Cap Growth C
JMVRX38.130.38
+1.01%
JPMorgan Mid Cap Value R5
PGRTX15.39N/A
N/A
Principal SmallCap Growth I Instl
UMBHX29.25N/A
N/A
Carillon Chartwell Small Cap I

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+10.42%
AKRO - ETNB
62%
Loosely correlated
+2.52%
PLRX - ETNB
47%
Loosely correlated
-0.74%
IDYA - ETNB
46%
Loosely correlated
-0.25%
ALLO - ETNB
44%
Loosely correlated
+4.35%
BEAM - ETNB
42%
Loosely correlated
+5.29%
More